Navigation Links
Cardica Announces Fiscal 2012 Second Quarter Financial Results
Date:2/6/2012

Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents at www.streetevents.com, a password-protected event management site.

About Cardica
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System, for coronary artery bypass graft (CABG) surgery and has shipped over 38,000 units throughout the world. In addition, Cardica is developing the Cardica MicroCutter XCHANGE™ 30, a cartridge-based microcutter device with a 5 millimeter shaft diameter, and the Cardica MicroCutter XPRESS 30, a true multi-fire laparoscopic stapling device designed to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter products require 510(k) review and are not yet commercially available in the U.S. The Cardica MicroCutter XCHANGE 30 and XPRESS 30 are not currently commercially available.

Forward-Looking Statements
This press release contains "forward-looking" statements, including all statements regarding the continued development, and application of the CE mark to the MicroCutter XCHANGE 30, as well as Cardica's expectations regarding future sales of its cardiac products. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words "look forward," "anticipate," "expect" and similar expressions are intended
'/>"/>

SOURCE Cardica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardica to Announce Fiscal 2012 Second Quarter Financial Results on Monday, February 6, 2012
2. Cardica Achieves Key Milestone With Over 25,000 PAS-Port® Proximal Anastomosis Systems Deployed Worldwide
3. Cardica Provides Update on MicroCutter™ Program
4. Cardica Achieves Second Milestone Under Century Distribution Agreement
5. Cardica to Present at Upcoming Investor Conferences
6. Cardica Announces Fiscal 2012 First Quarter Financial Results
7. Cardica Appoints Christopher Littel VP, Sales and Marketing
8. Cardica to Announce Fiscal 2012 First Quarter Financial Results on Thursday, October 27, 2011
9. Cardica Achieves Milestone Under Century Distribution Agreement
10. Cardicas Cardiac Anastomosis Device Featured in Clinical Presentation on Robotic Cardiac Bypass Procedures
11. Cardica Signs Distribution Agreement for MicroCutter in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Texas , Sept. 4, 2015  Luminex Corporation ... present at the Morgan Stanley Global Healthcare Conference to ... Grand Hyatt Hotel in New York City ... at 11:40 a.m. Eastern time on Friday, September 18, ... accessed at Luminex Corporation,s website at http://www.luminexcorp.com . ...
(Date:9/4/2015)... SOUTH PLAINFIELD, N.J. , Sept. 4, 2015 ... is pleased to announce five recipients of its ... to Realize Innovation, Vision and Empowerment), designed to ... the Duchenne muscular dystrophy (DMD) community. The announcement ... for the international World Duchenne Awareness Day on ...
(Date:9/4/2015)... Future Prospects for Companies in ... Rhinitis drugs - new study showing you trends, ... market for allergic rhinitis drugs heading? What are the ... report shows you potential revenues and other trends to ... 326 page report provides 273 tables, charts, and graphs. ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7
... , EXTON, Pa., Oct. 9 Kensey Nash ... release its earnings results for its first quarter ended September ... 22, 2009. , Joe Kaufmann, President and CEO, ... Thursday, October 22, 2009 at 9:00 A.M. Eastern Time. ...
... 9 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ... announced sale of shares of its Series D convertible ... institutional investors, representing gross proceeds to ADVENTRX of approximately ... from the offering to fund its operations during the ...
Cached Medicine Technology:Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 2ADVENTRX Pharmaceuticals Announces Closing of Financing 2ADVENTRX Pharmaceuticals Announces Closing of Financing 3
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability Experts ... the Year” awards at this year’s Microsoft Worldwide Partner Conference that was held ... the Year” Award Winner for Data Platform services, the 2015 HP and Microsoft ...
(Date:9/4/2015)... Francisco, CA (PRWEB) , ... September 04, 2015 ... ... Amini, announces that CEREC technology is now available at CitiDent. CEREC is a ... machinery. In addition to saving time for patients by eliminating the need for ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Mike Day, a ... 2007, will compete in the Ironman World Championships in Kona on October 10th. , ... incurred Traumatic Brain Injury (TBI) through combat and the cutting-edge treatments that restore their ...
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, a ... announced its only mission and research focus: Water Life Science®. In the current ... water evaporation is becoming dangerously accelerated. As a result of the global fresh ...
(Date:9/4/2015)... ME (PRWEB) , ... September 04, 2015 , ... ... focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at ... , Speakers at the 2015 symposium are doctors and researchers at the top ...
Breaking Medicine News(10 mins):Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... 22-hour procedure replaced 80% of severely disfigured woman,s face, ... A team of eight Cleveland Clinic surgeons has completed ... most of the woman,s face, including about 80 percent ... most of the sinuses, upper jaw -- essentially ...
... Calif., Dec. 17 Human Pheromone,Sciences, Inc. (OTC Bulletin ... filed a Comprehensive Patent Application with the U.S. Patent ... previously undeveloped,compound with its origin in sea coral, which ... feelings of positive social relationships,personal well-being and social attraction. ...
... LLC today announced positive results from a Phase 2 ... Multiple Sclerosis patients with documented cognitive dysfunction. , ... study, Cognition Pharmaceuticals reported, the active group obtained significantly ... learning, including the Brief Visuospatial Memory Test - Revised, ...
... Jude Children,s Research Hospital have answered a central question ... rise to tumors. Stem cells are immature cells that ... cells that compose the range of body tissues. In ... arise from mutant forms of stem cells. , ...
... Dec. 17 Time Life is proud to announce they have teamed ... a brand new fitness program set to dance hits of the ,70s, ... , Cheryl Burke has been dancing since the age ... titles around the world. For the past six television seasons, the ...
... Mass., Dec. 17 Hologic, Inc. (Nasdaq: HOLX ... medical imaging systems and surgical products dedicated to serving the ... first quarter fiscal 2009 operating results on Monday, February 2, ... will host a conference call on Monday, February 2, 2009 ...
Cached Medicine News:Health News:Doctors Describe First U.S. Face Transplant 2Health News:Doctors Describe First U.S. Face Transplant 3Health News:Doctors Describe First U.S. Face Transplant 4Health News:HPS Files Patent for Mood-Enhancing Compound Naturally Found in Sea Coral 2Health News:Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis 2Health News:Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis 3Health News:Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis 4Health News:Molecular marker identifies normal stem cells as intestinal tumor source 2Health News:Cheryl Burke of 'Dancing with the Stars' Joins Forces With Time Life To Create a Brand New Dance Workout, 'DISCO ABS' 2Health News:Cheryl Burke of 'Dancing with the Stars' Joins Forces With Time Life To Create a Brand New Dance Workout, 'DISCO ABS' 3Health News:Hologic, Inc. to Release First Quarter Fiscal 2009 Operating Results on Monday, February 2, 2009 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: